Now accepting submissions
Cancer & Metabolism is accepting submissions; please use the online submission system to submit your manuscript.
For all enquiries about the journal, please contact: editorial@cancerandmetabolism.com.
Editorial Board
Editors-in-Chief
- Chi Van Dang, Abramson Cancer Centre, University of Pennsylvania, USA
- Michael Pollak, McGill University and Lady Davis Research Institute, Canada
Senior Editors
- Kevin Brindle, University of Cambridge and Cancer Research UK, UK
- Eyal Gottlieb, Beatson Institute for Cancer Research, UK
Editorial Board
- Abass Alavi, University of Pennsylvania School of Medicine, USA
- Lewis Cantley, Harvard Medical School, USA
- Peter Carmeliet, Vesalius Research Center, Belgium
- Navdeep Chandel, Northwestern University, USA
- Ralph DeBerardinis, University of Texas Southwestern Medical Center, USA
- Teresa Fan, James Graham Brown Cancer Center and University of Louisville , USA
- Robert Gatenby, H. Lee Moffitt Cancer Center and Research Institute, USA
- Kun-Liang Guan, UC San Diego, USA
- Rudolf Kaaks, German Cancer Research Center, Germany
- Andrew Lane, James Graham Brown Cancer Center, USA
- Gordon Mills, University of Texas M. D. Anderson Cancer Center, USA
- Lorenz Poellinger, Karolinska Institute, Sweden
- Jacques Pouyssegur, Institute of Research on Cancer and Aging, Nice, France
- Joshua Rabinowitz, Princeton University, USA
- Peter Ratcliffe, Nuffield Department of Clinical Medicine, UK
- Jeffrey Rathmell, Duke University, USA
- Jared Rutter, University of Utah School of Medicine, USA
- David Sabatini, Whitehead Institute for Biomedical Research, USA
- Paolo Sassone-Corsi, UC Irvine, United States of America
- Gregg Semenza, Johns Hopkins University School of Medicine, USA
- Celeste Simon, University of Pennsylvania School of Medicine, USA
- Greg Stephanopoulos, Massachusetts Institute of Technology, USA
- Matthew Vander Heiden, Harvard Medical School, USA
- Alexei Vazquez, The Cancer Institute of New Jersey, USA
- Bert Vogelstein, John Hopkins University School of Medicine, USA
- Karen Vousden, Beatson Institute for Cancer Research, UK
- Eileen White, The Cancer Institute of New Jersey, USA
- Yue Xiong, UNC-Chapel Hill, USA
Aims & scope
Cancer & Metabolism welcomes studies on all aspects of the relationship between cancer and metabolism, including:
- &nsbp;Molecular biology and genetics of cancer metabolism
- &nsbp;Whole-body metabolism, including diabetes and obesity, in relation to cancer
- &nsbp;Metabolomics in relation to cancer
- &nsbp;Metabolism-based imaging
- &nsbp;Preclinical and clinical studies of metabolism-related cancer therapies
Editor profiles
Chi Van Dang
Chi Van Dang, MD, PhD is a professor, physician-researcher, renowned cancer biologist and hematologist-oncologist, who serves as director of the Abramson Cancer Center at the University of Pennsylvania.
"After several decades of profound advances in our understanding of the genetics and molecular biology of cancer, it has become self-evident that metabolism and bioenergetics are regulated by cancer genes and are intimately linked to the growth and survival of cancer cells. The obesity pandemic connected to increased cancer risk further underscore the importance of a richer understanding of cancer and organismal metabolism. In this regard, Cancer & Metabolism is launched uniquely to fulfil the needs of a burgeoning field which is at the crossroads of many scientific disciplines."
Michael Pollak
Dr Michael N. Pollak is an internationally recognised expert in cancer endocrinology at the Lady Davis Institute for Medical Research of McGill University and a clinical oncologist at the Jewish General Hospital, Quebec, Canada.
"Cancer & Metabolism will provide a forum for rapid dissemination of research findings concerning metabolic factors that influence cancer risk and cancer pathophysiology, and cancer treatment. The scope of the Journal will allow for an interdisciplinary readership including cancer biologists, endocrinologists, oncologists, clinical trialists and population scientists."
Email updates
Receive periodic news and updates relating to this journal.